243 related articles for article (PubMed ID: 35831044)
1. Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis protocol.
Lv W; Wang Q; Hu Q; Wang X; Cao D
BMJ Open; 2022 Jul; 12(7):e050558. PubMed ID: 35831044
[TBL] [Abstract][Full Text] [Related]
2. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
[TBL] [Abstract][Full Text] [Related]
3. Optimal dose-fractionation schedule of palliative radiotherapy for patients with bone metastases: a protocol for systematic review and network meta-analysis.
Tang X; Hu Q; Chen Y; Wang X; Li X; Cheng K; Cao D
BMJ Open; 2020 Jan; 10(1):e033120. PubMed ID: 31911518
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol.
Lee JC; Ahn S; Paik KH; Kim HW; Kang J; Kim J; Hwang JH
BMJ Open; 2016 Mar; 6(3):e010491. PubMed ID: 27016245
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
[TBL] [Abstract][Full Text] [Related]
6. Optimum duration of adjuvant trastuzumab in treatment of human epidermal growth factor receptor-2 positive early breast cancer: protocol for a network meta-analysis of randomised controlled trials.
Hu Q; Wang X; Chen Y; Li X; Luo T; Cao D
BMJ Open; 2020 Nov; 10(11):e035802. PubMed ID: 33444169
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant and/or adjuvant chemotherapy for gastric cancer patients with microsatellite instability or deficient mismatch repair: a systematic review and meta-analysis study protocol.
Liu B; Yin X; Cai Z; Shen C; Jiang T; Han Y; Yin Y; Zhang B
BMJ Open; 2024 Apr; 14(4):e084496. PubMed ID: 38670615
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant therapy for pancreatic cancer.
Gugenheim J; Crovetto A; Petrucciani N
Updates Surg; 2022 Feb; 74(1):35-42. PubMed ID: 34628591
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies.
Aroonsakul N; Phinyo P; Lumkul L; Jarupanich N; Szepietowski J; Chuamanochan M; Nochaiwong S
BMJ Open; 2022 Sep; 12(9):e062351. PubMed ID: 36691211
[TBL] [Abstract][Full Text] [Related]
10. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
Gillen S; Schuster T; Meyer Zum Büschenfelde C; Friess H; Kleeff J
PLoS Med; 2010 Apr; 7(4):e1000267. PubMed ID: 20422030
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of TRIANGLE operation applied in pancreatic surgery: a protocol of the systematic review and meta-analysis.
Wei K; Klotz R; Kalkum E; Holze M; Probst P; Hackert T
BMJ Open; 2022 Sep; 12(9):e059977. PubMed ID: 36691122
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.
Paiella S; Malleo G; Simoni N; Micera R; Guariglia S; Cavedon C; Marchegiani G; Esposito A; Landoni L; Casetti L; Tuveri M; Milella M; Secchettin E; Manzini G; Bovo C; De Pastena M; Fontana M; Salvia R; Mazzarotto R; Bassi C
BMC Cancer; 2021 Feb; 21(1):165. PubMed ID: 33593311
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-based split stereotactic body radiation therapy for borderline resectable and locally advanced pancreatic cancer: study protocol of a prospective, single-arm phase II trial.
Zheng R; Wang C; Huang X; Lin Q; Huang D; Li XB; Huang H; Xu B
BMJ Open; 2020 Nov; 10(11):e039900. PubMed ID: 33154057
[TBL] [Abstract][Full Text] [Related]
14. Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis.
Pan L; Fang J; Tong C; Chen M; Zhang B; Juengpanich S; Wang Y; Cai X
World J Surg Oncol; 2019 Dec; 18(1):1. PubMed ID: 31892339
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: a protocol for a systematic review and network meta-analysis.
Bae K; Song SY
BMJ Open; 2020 May; 10(5):e033461. PubMed ID: 32371507
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: study protocol for an open-label, multicentre, prospective phase II trial (JASPAC05).
Takahashi S; Ohno I; Ikeda M; Kobayashi T; Akimoto T; Kojima M; Konishi M; Uesaka K
BMJ Open; 2017 Oct; 7(10):e018445. PubMed ID: 29061632
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer-A Systematic Review and Meta-Analysis.
Damm M; Efremov L; Birnbach B; Terrero G; Kleeff J; Mikolajczyk R; Rosendahl J; Michl P; Krug S
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503138
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of exercise training program in patients with heart failure: protocol for a systematic review of randomised controlled trials and network meta-analysis.
Gao M; Huang Y; Wang Q; Gu Z; Sun G
BMJ Open; 2021 Mar; 11(3):e043160. PubMed ID: 33727267
[TBL] [Abstract][Full Text] [Related]
19. Which is the optimal adjuvant chemotherapy for resected pancreatic ductal adenocarcinoma?: A protocol for a network meta-analysis of randomized controlled trials.
Hu Q; Wang X; Chen Y; Li X; Cao P; Cao D
Medicine (Baltimore); 2019 May; 98(21):e15761. PubMed ID: 31124963
[TBL] [Abstract][Full Text] [Related]
20. The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
Brunner TB; Scott-Brown M
Radiat Oncol; 2010 Jul; 5():64. PubMed ID: 20615227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
